India Plays a Pivotal Role in the Global Fight Against Antibiotic Resistance

PORTO SEGURO, Brazil - March 2, 2025 - PRLog -- Showcasing India's Advances in Infection Control at the 3rd Russian Congress on Medical Microbiology & Infectology
Hyderabad, 2nd  March, 2025: Dr. Ranga Reddy Burri, President of the Infection Control Academy of India (IFCAI), proudly represented India at the 3rd Russian Congress on Medical Microbiology & Infectology held at the Radisson Slaviayanskiya, Moscow, on March 1st. He delivered a keynote presentation on "Innovations in Antimicrobial Therapies and Diagnostics: Navigating Controversies in Antimicrobial Treatment Management in India."
Addressing a distinguished audience of global medical experts, Dr. Burri emphasized the growing challenge of antimicrobial resistance (AMR), a pressing issue that threatens effective infectious disease management in India. He highlighted the urgent need for innovative therapies and advanced diagnostics to combat AMR and improve patient outcomes.
Key insights from Dr. Burri's presentation included:
- Next-Generation Antibiotics – Bacteriophage-based therapy, CRISPR-Cas antimicrobials, and microbiome-derived agents.
- Revolutionary Diagnostic Tools – AI-driven molecular diagnostics, biological imaging, and rapid DNA amplification technologies.
- One Health Approach – A holistic strategy integrating human, animal, and environmental health to tackle AMR.
- Stewardship & Public Awareness – The critical role of responsible antimicrobial use and community education.
Dr. Burri emphasized the importance of global collaboration and investment in research & development to drive innovation in antimicrobial therapies. He urged policymakers and healthcare institutions to prioritize AMR mitigation strategies to safeguard public health.
His participation at the prestigious Russian Congress underscores India's growing influence in infection control and antimicrobial stewardship on the global stage.